Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
PlexusDx recommends monitoring your injection sites for the first two weeks of therapy to distinguish normal from concerning reactions
Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes, not weight management (Wegovy is the licensed weight management product)
Well ship your treatment within 1-3 days in discreet packaging, with clear instructions included
10.1016/j.diabres.2015.07.015 83 SundstrmJ.BruzeG.OttossonJ.MarcusC.NslundI.NeoviusM
In a combined fertility and embryo-fetal development study in rats, subcutaneous doses of 0.01, 0.03 and 0.09 mg/kg/day (0.06-, 0.2-, and 0.6-fold the MRHD) were administered to male and female rats
Semaglutide users experienced a mean weight loss of 14.9% at week 68
